09 Dec 2020 --- Evolva has secured CHF12 million (US$13.3 million) in funding from Nice & Green, an independent company specializing in corporate financing, also based in Switzerland. It is the maximum principal amount that the health ingredients supplier can draw over a period of 12 months. Evolva says that it is “proactively creating financial flexibility” amid the limited market visibility during the COVID-19 crisis.
